News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 765 results

CMA accuses 4 pharma companies of anti-competitive conduct

UK24-05-2019

Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service, according to objections filed by the UK Competition and Markets Authority.

‘Considerable increase’ in pay-for-delay settlements: FTC report

US24-05-2019

The number of ‘pay-for-delay’ patent settlements reached in fiscal year 2016 represented a “considerable increase” from the previous year, according to a Federal Trade Commission report released yesterday, May 23, though there has been a considerable reduction in the most problematic settlements since 2013.

Eli Lilly releases generic insulin injection

US23-05-2019

Eli Lilly has released a generic insulin injection at half of the list price of its identical branded medicine to the US market.

City of Baltimore accuses Janssen of delaying generics

US23-05-2019

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is being sued for “unlawfully” delaying generic competition to Zytiga, its branded cancer medication.

Federal Circuit invalidates Nuvo’s Vimovo patents

US17-05-2019

The US Court of Appeals for the Federal Circuit has delivered a blow to Nuvo Pharmaceuticals by reversing a decision which had upheld the validity of the Canadian company’s pain relief drug Vimovo.

EU adopts SPC manufacturing waiver

EU16-05-2019

The European Union has adopted the proposed supplementary protection certificate manufacturing waiver, despite criticism from parts of the pharmaceutical industry.

Federal Circuit rules against J&J in Zytiga dispute

US16-05-2019

The US Court of Appeals for the Federal Circuit delivered a blow to Johnson & Johnson on Tuesday, May 14, by confirming the invalidation of a patent covering blockbuster prostate cancer drug Zytiga.

Clean sweep for AbbVie in Humira litigation

US15-05-2019

Boehringer Ingelheim has become the latest biosimilar maker to resolve litigation over AbbVie’s arthritis treatment Humira.

44 states accuse big pharma of price fixing generics market

US13-05-2019

44 US states have filed a joint complaint against 20 drug companies, alleging they engaged in illegal conspiracies to “manipulate prices, reduce competition” and restrain trade for more than 100 generic drugs.

E+F patent attorney elevated to partner

UK13-05-2019

Elkington + Fife has unveiled Mark Scott as a new partner in the UK firm’s patent practice.

Showing 1 to 10 of 765 results

LSIPR